# Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.

> **NCT02056223** · PHASE2,PHASE3 · SUSPENDED · sponsor: **University of Padova** · enrollment: 120 (estimated)

## Conditions studied

- Ductus Arteriosus Patent
- Respiratory Distress Syndrome

## Interventions

- **DRUG:** Intravenous paracetamol
- **DRUG:** Intravenous ibuprofen

## Key facts

- **NCT ID:** NCT02056223
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-01-09
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 120 (ESTIMATED)
- **Why stopped:** We enrolled only 53 patients
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02056223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02056223, "Paracetamol vs Ibuprofen for PDA Closure in Preterm Infants.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02056223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*